Human Oncology & Pathogenesis Program

Our teams of physician-scientists are working to translate molecular insights into new treatments for cancer.

Learn more »
As a member of HOPP, Ingo Mellinghoff cares for patients with brain cancer and also leads a laboratory focused on understanding the genetic causes of brain tumors.
Pictured: Ingo Mellinghoff

Browse our lab heads

Select...

HOPP Progress Report

One of the goals of the Human Oncology and Pathogenesis Program (HOPP) is to achieve progress in various areas of cancer research. In our 2006-2010 progress report, learn about our collaborations, innovations, and training that have had an impact on Memorial Sloan-Kettering and its patients.

View progress report »

Launch and share on social media »

Pictured: 2011 Summer Students
Apply for Our Summer Student Program

High school students from underserved populations who are interested in pursuing careers in the biomedical sciences can apply for our summer student program. The application is open through March 1, 2012.

Pictured: 2011 Summer Students
Pictured: Charles Sawyers
An Interview with Charles Sawyers

Charles Sawyers sees an opportunity for the next generation of physician-scientists to fuel a genetic medicine revolution at Memorial Sloan-Kettering.

Pictured: Charles Sawyers
Pictured: David Solit
Researchers Discover Why New Melanoma Drug Stops Working

Research led by investigators at Memorial Sloan-Kettering has identified a previously unknown mechanism of resistance to the newly approved melanoma drug, vemurafenib.

Pictured: David Solit
Pictured: Scott Lowe
Geoffrey Beene Cancer Research Center

The Geoffrey Beene Center unites researchers from the Human Oncology and Pathogenesis Program and the Sloan-Kettering Institute’s Cancer Biology and Genetics Program to develop new approaches for preventing, diagnosing, and treating cancer.

Pictured: Scott Lowe